Whitefort capital publishes open letter to arbutus biopharma shareholders outlining paths to maximize value

New york--(business wire)--whitefort capital management, lp (together with its affiliates, “whitefort capital,” “us” or “we”), which is a long-term investor and the second largest shareholder of arbutus biopharma corp. (nasdaq: abus) (“arbutus” or the “company”) with an ownership interest of approximately 6.8% of the company's outstanding shares, today published an open letter to shareholders outlining its views of the best paths forward to maximize value. the full text of the letter is below:.
ABUS Ratings Summary
ABUS Quant Ranking